Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study
暂无分享,去创建一个
J. Halfvarson | C. Söderman | O. Grip | H. Hjortswang | J. Gunnarsson | R. Udumyan | J. Marsal | D. Bergemalm | P. Karlén | H. Strid | E. Hertervig | C. Eriksson | S. Almér | S. Rundquist | Carolina Malmgren | M. Sjöberg | V. Lykiardopoulos | Jenny Delin | David Öberg